Texas AG sues Permian Basin Containers for environmental violations

Texas Attorney General Ken Paxton filed a lawsuit against Permian Basin Containers, LLC and related entities for environmental violations stemming from a catastrophic chemical fire at their Odessa facility on July 23, 2024. The fire released toxic substances including benzene into the air, soil, and groundwater, contaminating surrounding properties and endangering residents. The state seeks injunctive relief requiring full site remediation and recovery of cleanup costs and damages.

Paxton sues dental providers for Medicaid fraud, unnecessary procedures

Texas Attorney General Ken Paxton filed suit against dental providers and marketers for allegedly bribing Medicaid patients with gift cards and performing medically unnecessary dental procedures, defrauding Texas Medicaid. The lawsuit, brought under the Texas Health Care Program Fraud Prevention Act, seeks full restitution, civil penalties, and all available remedies. The case was initially sealed and has now been unsealed.

California AG $1.64M Settlement Over False Claims for Truck Reimbursements

California Attorney General Rob Bonta announced a $1.64 million settlement with commercial fleet lender Crossroads Equipment Lease and Finance over alleged false claims for reimbursements under the California Capital Access Program (CalCAP). A DOJ investigation validated whistleblower claims that Crossroads made minimal efforts to sell repossessed trucks knowing the program would reimburse losses. The settlement resolves claims raised under the California False Claims Act by a former Chief Risk Officer.

Lung cancer Phase 3 trial evaluating BL-B01D1 combination therapy

The National Library of Medicine registered a Phase 3 clinical trial (NCT07502300) on ClinicalTrials.gov evaluating BL-B01D1 combination therapy for lung cancer. This is a standard clinical trial registration providing public transparency about ongoing research. The trial involves evaluating the efficacy and safety of BL-B01D1 as a treatment intervention.

AI cognitive-behavioral therapy trial, major depressive disorder, Taiwan

ClinicalTrials.gov registered a new Phase 2 clinical trial (NCT07500714) evaluating AI-assisted cognitive-behavioral therapy for adult patients with major depressive disorder. The single-arm trial is conducted at National Taiwan University Hospital in Taiwan. The study uses the Woebot Health AI platform combined with standard pharmacotherapy over a 10-week intervention period.

HBS-301 Tablet Phase 3 for Idiopathic Hypersomnia

The National Institutes of Health posted a new clinical trial registration on ClinicalTrials.gov for HBS-301 tablets in Phase 3 evaluation for idiopathic hypersomnia. The trial is listed as currently recruiting participants. This registry posting does not impose new regulatory requirements but reflects compliance with clinical trial registration obligations.

Phase 3 Libevitug study for chronic HDV infection

The National Library of Medicine registered a Phase 3 clinical trial (NCT07499544) for Libevitug in chronic hepatitis D virus (HDV) infection on ClinicalTrials.gov. The trial is listed with standard registry metadata including sponsor information and study design. No specific regulatory deadlines or penalties are associated with this registration notice.

NexCAR19 CAR-T Trial for B-Cell Malignancies in Turkey

ClinicalTrials.gov registered a new CAR-T cell therapy trial (NCT07502118) evaluating NexCAR19 for treatment of B-cell malignancies in Turkey. The study is listed as a single-arm trial investigating a locally manufactured CAR-T product in patients with relapsed or refractory B-cell cancers.

Psilocybin therapy Indiana University depression trial

Psilocybin therapy Indiana University depression trial

Education Tax Credit Scholarship Values for 2026-2027

The NH Department of Revenue Administration issued Technical Information Release 2026-001 announcing the adjusted allowable average value of Education Tax Credit scholarships for the 2026-2027 program year. The program year runs from July 1, 2026 through June 30, 2027. This routine annual adjustment updates scholarship values that participating businesses and nonprofits use to determine tax credit amounts under the Education Tax Credit Program.